Bilateral otitis media and mastoiditis caused by a highly resistant strain of Mycobacterium chelonae

Pediatric Infectious Disease Journal

Volumn 15, Issue 11, 1996, Pages 1037-1040

  Avery, Robin K ^a   Eavey, Roland D ^b   Della Torre, Thomas ^c   Ramos, Dante ^c   Pasternack, Mark S ^d  

^a LERNER RESEARCH INSTITUTE   (United States)

^b MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^c Papazian Tarro and Della Torre Inc ^*

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

imipenem; mastoiditis; Mycobacterium chelonae; Otitis media

Indexed keywords

CEFACLOR; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; NAFCILLIN; SULFAFURAZOLE; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CHILD; FEMALE; HUMAN; MASTOIDITIS; MYCOBACTERIUM CHELONEI; OTITIS MEDIA; PRIORITY JOURNAL;

CHILD, PRESCHOOL; CHRONIC DISEASE; DEBRIDEMENT; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMANS; MASTOIDITIS; MIDDLE EAR VENTILATION; MYCOBACTERIUM CHELONAE; MYCOBACTERIUM INFECTIONS, ATYPICAL; OTITIS MEDIA;

EID: 0029845881     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199611000-00020     Document Type: Article

References (46)

1. Wallace RJ Jr, Swenson JM, Silcox VA, Good RC, Txchen JA, Stone MS. Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis 1983;5:657-79.
2. Hand WL, Sanford JP. Mycobacterium fortuitum: a human pathogen. Ann Intern Med 1970;73:971-7.
3. McFarland EJ, Kuritzkes DR. Clinical features and treatment of infection due to Mycobacterium fortuitum / chelonae complex. Curr Clin Top Infect Dis 1993;13:188-202.
4. Lowry PW, Jarvis WR, Oberle AD, et al. Mycobacterium chelonae causing otitis media in an ear-nose-and-throat practice. N Engl J Med 1988;319:978-82.
5. Sanders WE Jr, Horowitz EA. Other Mycobacterium species. In: Mandell GR, Douglas RG Jr, Bennett JR, eds. Principles and practice of infectious diseases. 3rd ed. New York: Churchill Livingstone, 1990:1914-26.
6. McWhinney PHM, Yates M, Prentice HG, et al. Infection caused by Mycobacterium chelonae: a diagnostic and therapeutic problem in the neutropenic patient. Clin Infect Dis 1992;14:1208-12.
7. Robicsek F, Daugherty HK, Cook JW, et al. Mycobacterium fortuitum epidemics after open heart surgery. J Thorac Cardiovasc Surg 1978;75:91-6.
8. Hoffman PC, Fraser DW, Robicsek F, et al. Two outbreaks of sternal wound infections due to organisms of the Mycobacterium fortuitum complex. J Infect Dis 1981;143:533-42.
9. Kuritsky JN, Bullen MG, Broome CV, et al. Sternal wound infections and endocarditis due to organisms of the Mycobacterium fortuitum complex. Ann Intern Med 1983;98:938-9.
10. Grange JM. Mycobacterial infections following heart valve replacement. J Heart Valve Dis 1992;1:102-9.
11. Clegg HW, Foster MT, Sanders WE Jr, et al. Infection due to organisms of the Mycobacterium fortuitum complex after augmentation mammaplasty: clinical and epidemiologic features. J Infect Dis 1983;147:427-33.
12. Bolan G, Reingold AL, Carson LA, et al. Infections with Mycobacterium chelonei in patients receiving dialysis and using processed hemodialyzers. J Infect Dis 1985;152: 1013-9.
13. Band JD, Ward JI, Fraser DW, et al. Peritonitis due to a Mycobacterium chelonei-like organism associated with intermittent chronic peritoneal dialysis. J Infect Dis 1982;145:9-17.
14. Khooshabeh R, Grange JM, Yates MD, McCartney AC, Casey TA. A case report of Mycobacterium chelonae keratitis and a review of mycobacterial infections of the eye and orbit. Tuber Lung Dis 1994;75:377-82.
15. Zahid MA, Klotz SA, Goldstein E, Bartholomew W. Mycobacterium chelonae (M. chelonae subspecies chelonae): report of a patient with a sporotrichoid presentation who was successfully treated with clarithromycin and ciprofloxacin. Clin Infect Dis 1994;18:999-1001.
16. Johnson S, Weir TW. Multiple cutaneous ulcers of the legs: Mycobacterium chelonae infection. Arch Dermatol 1993;129: 1190-1, 1193.
17. Eichmann A, Huszar A, Bon A. Mycobacterium chelonae infection of lymph nodes in an HIV-infected patient. Dermatology 1993;187:299-300.
18. Sanders WE Jr. Lung infection caused by rapidly growing mycobacteria. J Respir Dis 1982;3:30-8.
19. Singh N, Yu VL. Successful treatment of pulmonary infection due to Mycobacterium chelonae: case report and review. Clin Infect Dis 1992;14:156-61.
20. Idemyor V, Cherubin CE. Retroperitoneal abscess caused by Mycobacterium chelonae and treatment. Ann Pharmacother 1993;27:178-9.
21. Alvi A, Myssiorek D. Mycobacterium chelonae causing recurrent neck abscess. Pediatr Infect Dis J 1993;12:617-9.
22. Repath F, Seabury JH, Sanders CV, et al. Prosthetic valve endocarditis due to Mycobacterium chelonei. South Med J 1976;69:1244-6.
23. Pruitt TC, Hughes LO, Blasier RD, et al. Atypical mycobacterial vertebral osteomyelitis in a steroid-dependent adolescent: a case report. Spine 1993;18:2553-5.
24. Soto LE, Bobadilla M, Villalobos Y, et al. Post-surgical nasal cellulitis outbreak due to Mycobacterium chelonae. J Hosp Infect 1991;19:99-106.
25. Raad II, Vartivarian S, Khan A, Bodey GP. Catheter-related infections caused by the Mycobacterium fortuitum complex: 15 cases and review. Rev Infect Dis 1991;13:1120-5.
26. Tice AD, Solomon RJ. Disseminated Mycobacterium chelonei infection: response to sulfonamides. Am Rev Respir Dis 1979;120:197-201.
27. Wallace RJ Jr, Tanner D, Brennan PJ, Brown BA. Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. Ann Intern Med 1993;119: 482-6.
28. Ingram CW, Tanner DC, Durack DT, Kernodle GW Jr, Corey GR. Disseminated infection with rapidly growing mycobacteria [Review]. Clin Infect Dis 1993;16:463-71.
29. Swetter SM, Kindel SE, Smoller BR. Cutaneous nodules of Mycobacterium chelonae in an immunosuppressed patient with preexisting pulmonary colonization. J Am Acad Dermatol 1993;28(2 Pt 2):352-5.
30. Austin WK, Lockey MW. Mycobacterium fortuitum mastoiditis. Arch Otolaryngol 1976;102:558-60.
31. Neitch SM, Sydnor JB, Schleupner CJ. Mycobacterium fortuitum as a cause of mastoiditis and wound infection. Arch Otolaryngol 1982;108:11-4.
32. Plemmons RM, McAllister K, Liening DA, Garces MC. Otitis media and mastoiditis due to Mycobacterium fortuitum: case report, review of four cases, and a cautionary note. Clin Infect Dis 1996;22:1105-6.
33. Wallace RJ Jr. Nontuberculous mycobacteria and water: a love affair with increasing clinical importance. Infect Dis Clin North Am 1987;1:677-86.
34. Gremillion DH, Mursch SB, Lerner CJ. Injection site abscesses caused by Mycobacterium chelonei. Infect Control 1983;4:25-8.
35. Safranek TJ, Jarvis WR, Carson LA, et al. Mycobacterium chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution. N Engl J Med 1987;317:197-201.
36. Fraser VJ, Jones M, Murray PR, et al. Contamination of flexible fiberoptic bronchoscopes with Mycobacterium chelonae linked to an automated bronchoscope disinfection machine. Am Rev Respir Dis 1992;145(4 Pt 1):8:53-5
37. Wallace RJ Jr, Steele LC, Labidi A, Silcox VA. Heterogeneity among isolates of rapidly growing mycobacteria responsible for infections following augmentation mammaplasty despite case clustering in Texas and other southern coastal states. J Infect Dis 1989;160:281-88.
38. Wallace RJ Jr, Musser JM, Hull SI, et al. Diversity and sources of rapidly growing mycobacteria associated with infections following cardiac surgery. J Infect Dis 1989;159: 708-16.
39. Wallace RJ Jr, Dalovisio JR, Pankey GA. Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents. Antimicrob Agents Chemother 1979;16:611-14.
40. Wallace RJ Jr, Jones DB, Wiss K Sulfonamide activity against Mycobacterium. fortuitum and Mycobacterium chelonei. Rev Infect Dis 1981;3:898-904.
41. Dalovisio JR, Pankey GA, Wallace RJ, Jones DB. Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei. Rev Infect Dis 1981;3:1068-74.
42. Wallace RJ Jr, Swenson JM, Silcox VA, Bullen MG. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities. J Infect Dis 1985;152:500-14.
43. Swenson JM, Wallace RJ Jr, Silcox VA, Thornsberry C. Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae. Antimicrob Agents Chemother 1985;28:807-11.
44. Yew WW, Lau KS, Tse WK, Wong CF. Imipenem in the treatment of lung infections due to Mycobacterium fortuitum and Mycobacterium chelonae: further experience [Letter]. Clin Infect Dis 1992;15:1046-7.
45. Matoba AY, Lee BL, Robinson NM, Penland R, Osato MS. Combination drug testing of Mycobacterium chelonae. Invest Ophthalmol Vis Sci 1993;34:2786-9.
46. Heifets LB. Antimycobacterial drugs. Semin Respir Infect 1994;9:84-103.